NO20072155L - Clostridium-nevrotoksiner for anvendelse i vevheling - Google Patents

Clostridium-nevrotoksiner for anvendelse i vevheling

Info

Publication number
NO20072155L
NO20072155L NO20072155A NO20072155A NO20072155L NO 20072155 L NO20072155 L NO 20072155L NO 20072155 A NO20072155 A NO 20072155A NO 20072155 A NO20072155 A NO 20072155A NO 20072155 L NO20072155 L NO 20072155L
Authority
NO
Norway
Prior art keywords
neurotoxins
tissue
clostridium
local administration
clostridium neurotoxins
Prior art date
Application number
NO20072155A
Other languages
English (en)
Norwegian (no)
Inventor
Harold Victor Taylor
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of NO20072155L publication Critical patent/NO20072155L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20072155A 2004-09-27 2007-04-26 Clostridium-nevrotoksiner for anvendelse i vevheling NO20072155L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61339204P 2004-09-27 2004-09-27
PCT/GB2005/003728 WO2006035225A1 (en) 2004-09-27 2005-09-27 Clostridial neurotoxins for use in tissue healing

Publications (1)

Publication Number Publication Date
NO20072155L true NO20072155L (no) 2007-04-26

Family

ID=35355850

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072155A NO20072155L (no) 2004-09-27 2007-04-26 Clostridium-nevrotoksiner for anvendelse i vevheling

Country Status (13)

Country Link
US (1) US20060067950A1 (pt)
EP (1) EP1799254A1 (pt)
KR (1) KR20070057862A (pt)
CN (1) CN101027083A (pt)
AU (1) AU2005288758A1 (pt)
BR (1) BRPI0516134A (pt)
CA (1) CA2580122A1 (pt)
EA (1) EA200700739A1 (pt)
IL (1) IL182153A0 (pt)
MX (1) MX2007003407A (pt)
NO (1) NO20072155L (pt)
WO (1) WO2006035225A1 (pt)
ZA (1) ZA200702484B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220422B2 (en) 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
AR061669A1 (es) 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
WO2015126527A1 (en) * 2014-02-18 2015-08-27 Kaufman-Janette Joely Botulinum neurotoxin for use in the prophylactic treatment of cutaneous wounds
WO2018175696A1 (en) * 2017-03-22 2018-09-27 Bonti, Inc. Botulinum neurotoxins for treating traumatic injuries
EP3600221A4 (en) * 2017-03-22 2021-01-13 Bonti, Inc. BOTULINARY NEUROTOXINS FOR USE IN THERAPY
CN107469065B (zh) * 2017-07-19 2021-05-18 广州医科大学 类蛇毒三胜肽在制备用于治疗皮肤溃疡的药物中的应用
US20190183987A1 (en) * 2017-12-18 2019-06-20 Bonti, Inc. Neurotoxins for use in minimizing scarring

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69620888T2 (de) * 1996-11-27 2002-08-14 William J. Binder Neurotoxine zur Behandlung von Hauterkrankungen bei Säugetieren
WO2000024419A1 (en) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders

Also Published As

Publication number Publication date
CA2580122A1 (en) 2006-04-06
WO2006035225A1 (en) 2006-04-06
ZA200702484B (en) 2008-11-26
EP1799254A1 (en) 2007-06-27
EA200700739A1 (ru) 2007-10-26
AU2005288758A1 (en) 2006-04-06
KR20070057862A (ko) 2007-06-07
IL182153A0 (en) 2007-07-24
US20060067950A1 (en) 2006-03-30
BRPI0516134A (pt) 2008-08-26
MX2007003407A (es) 2007-05-23
CN101027083A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
NO20072155L (no) Clostridium-nevrotoksiner for anvendelse i vevheling
ECSP077328A (es) Neurotoxinas clostridiales para uso en la cicatrización de tejidos
Bharadia et al. Hypertrophic scar
BR112016003358A2 (pt) método para aumentar a expressão de proteínas codificadas por rna
MX2011007059A (es) Formulaciones inyectables de toxinas de botulino.
WO2009142772A3 (en) Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
MX2021009696A (es) Vectores de genoterapia para el tratamiento de la enfermedad de danon.
CO6640331A2 (es) Tratamiento anti-envejecimiento de la piel
NZ710157A (en) Use of guanethidine for treating hypertension by local vascular delivery
BRPI0922789A2 (pt) peptídeo de ligação de albumina intermediador para reconhecimento de doença
Hong et al. Impending skin necrosis after dermal filler injection: a “golden time” for first‐aid intervention
MY190257A (en) Optimised subcutaneous therapeutic agents
Arenbergerova et al. Effect of topical haemoglobin on venous leg ulcer healing.
BRPI0911650B8 (pt) peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
ATE444076T1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
CY1117854T1 (el) Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
Siperstein et al. A split‐face, blind, randomized placebo‐controlled clinical trial investigating the efficacy and safety of hyaluronic acid filler for the correction of atrophic facial scars
JP2020511548A5 (pt)
ES2525009T3 (es) Glucoproteínas que tienen propiedades de movilización de lípidos y usos terapéuticos de las mismas
BRPI0800085A2 (pt) composição farmacêutica e curativo para tratamento de lesões de pele, bem como uso de sal de cério associado a uma matriz de colágeno
CY1116672T1 (el) Χρηση αδαπαλενης και βενζοϋλυπεροξειδιου για την μακροχρονια αντιμετωπιση της κοινης ακμης
EA201270747A1 (ru) Композиции и способы для профилактики и лечения ран
ES2421407T3 (es) Agente y composición para la curación de heridas
EP4588487A3 (en) Treatment of warts
EA201171352A1 (ru) Антигенсвязывающие фрагменты антитела и их применение для лечения или диагностики глазных болезней

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application